Among the variants of urothelial carcinoma, the micropapillary variant of urothelial carcinoma showed a higher incidence of HER2 gene amplification and HER2 protein overexpression than conventional urothelial carcinoma. This evidence concerns the gene ERBB2 and urothelial carcinoma.